3 results
Approved WMOCompleted
To explore the safety, tolerability and the pharmacokinetic profile of 2-IB when given on top of therapeutic hypothermia.
Approved WMOCompleted
Primary Objective: To develop a protocol for NMES for dysphagia to determine optimal electrode placement and stimulation parameters in MS patients.Secondary Objective: To determine variability in location, morphology, and type of motor dysfunctions…
Approved WMOCompleted
The primary objective of this study is to evaluate the short term safety and tolerability, and pharmacokinetic properties of 2-IB when administered to adult patients after OHCA. Secondary objectives include safety and efficacy parameters at 30 days…